Organization
Department of Medicine (DIMED) University of Padua and Veneto Institute of Oncology (IOV-IRCCS )
2 abstracts
Abstract
Highly prognostic signature for stage II colon cancer from the TOSCA trial: The PROSIT study.Org: IEO, European Institute of Oncology IRCCS, Medical Oncology Unit 1, Universita Di Genova, Medical Oncology 1, Istituto Oncologico Veneto, IOV - IRCCS, Istituto di Ricerche Farmacologiche Mario Negri,
Abstract
Understanding resistance in V600E BRAF advanced colon cancer treated with BRAF inhibitors plus anti-EGFR antibodies +/- MEK inhibitors: The URBAN study.Org: Medical Oncology 1, Venetian Institute of Oncology-IRCCS, Padua, Padua, Italy, Department of Oncology and Haematology, Division of Oncology, University Hospital of Modena, Modena, Italy, Veneto Institute of Oncology IOV–IRCCS, Padua, Italy, Department of Medicine (DIMED) University of Padua and Veneto Institute of Oncology (IOV-IRCCS ),